Psychoneuroimmunological pathways involved in acute coronary syndromes

Psychoneuroimmunology, Two-Volume Set

Volumn 2, Issue , 2007, Pages 921-943

  Kop, Willem J ^a   Cohen, Nicholas ^b  

^a Uniformed Services University of the Health Sciences and the Walter Reed National Military Medical Center   (United States)

^b UNIVERSITY OF ROCHESTER SCHOOL OF MEDICINE AND DENTISTRY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 67650138847     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-012088576-3/50051-4     Document Type: Chapter

References (197)

1. Cannon W.B. The wisdom of the body 1939, WW Norton and Company, New York. 2nd ed.
2. Matzinger P. Tolerance, danger, and the extended family. Annu. Rev. Immunol. 1994, 12:991-1045.
3. Steptoe A., Brydon L. Psychoneuroimmunology and coronary heart disease. Human psychoneuroimmunology 2005, 107-135. Oxford University Press, Oxford. K. Vedhara, M. R. Irwin (Eds.).
4. Adams D.O. Molecular biology of macrophage activation: a pathway whereby psychosocial factors can potentially affect health. Psychosom. Med. 1994, 56:316-327.
5. Ader R., Cohen N., Felten D. Psychoneuroimmunology: interactions between the nervous system and the immune system. Lancet 1995, 345:99-103.
6. Alonzo A.A., Simon A.B., Feinleib M. Prodromata of myocardial infarction and sudden death. Circulation 1975, 52:1056-1062.
7. Ambrose J.A., Tannenbaum M.A., Alexopoulos D., Hjemdahl-Monsen C.E., Leavy J., Weiss M., et al. Angiographic progression of coronary artery disease and the development of myocardial infarction. J. Am. Coll. Cardiol. 1988, 12:56-62.
8. Appels A. Mental precursors of myocardial infarction. British Journal of Psychiatry 1990, 156:465-471.
9. Appels A. Depression and coronary heart disease: observations and questions. Journal of Psychosomatic Research 1997, 43:443-452.
10. Appels A., Bar F., Lasker J., Flamm U., Kop W. The effect of a psychological intervention program on the risk of a new coronary event after angioplasty: a feasibility study. Journal of Psychosomatic Research 1997, 43:209-217.
11. Appels A., Bar F., Van Der P.G., Erdman R., Assman M., Trijsburg W., et al. Effects of treating exhaustion in angioplasty patients on new coronary events: results of the randomized exhaustion intervention trial (exit) Psychosom. Med. 2005, 67:217-223.
12. Appels A., Bar F.W., Bar J., Bruggeman C., De Baets M. Inflammation, depressive symptomatology, and coronary artery disease. Psychosom. Med. 2000, 62:601-605.
13. Appels A., Kop W.J., Meesters C.M., Markusse R., Golombeck B., Falger P.R. Vital exhaustion and the acute coronary syndromes. International review of health psychology 1994, 65-95. John Wiley and Sons, Ltd., New York. S. Maes, H. Leventhal, M. Johnston (Eds.).
14. Appels A., Mulder P. Excess fatigue as a precursor of myocardial infarction. Eur. Heart J. 1988, 9:758-764.
15. Appels A., Otten F. Exhaustion as precursor of cardiac death. British Journal of Clinical Psychology 1992, 31:351-356.
16. Barefoot J.C., Dahlstrom W.G., Williams R.B. Hostility, Chd incidence, and total mortality: a 25-year follow-up study of 255 physicians. Psychosom. Med. 1983, 45:59-63.
17. Beck J., Garcia R., Heiss G., Vokonas P.S., Offenbacher S. Periodontal disease and cardiovascular disease. Journal of Periodontology 1996, 67:1123-1137.
18. Benschop R.J., Geenen R., Mills P.J., Naliboff B.D., Kiecolt-Glaser J.K., Herbert T.B., et al. Cardiovascular and immune responses to acute psychological stress in young and old women: a meta-analysis. Psychosom. Med. 1998, 60:290-296.
19. Benschop R.J., Godaert G.L., Geenen R., Brosschot J.F., De Smet M.B., Olff M., et al. Relationships between cardiovascular and immunological changes in an experimental stress model. Psychological Medicine 1995, 25:323-327.
20. Benschop R.J., Rodriguez-Feuerhahn M., Schedlowski M. Catecholamine-induced leukocytosis: early observations, current research, and future directions. Brain Behav. Immun. 1996, 10:77-91.
21. Berkman L.F., Blumenthal J., Burg M., Carney R.M., Catellier D., Cowan M.J., et al. Effects of treating depression and low perceived social support on clinical events after myocardial infarction: the Enhancing Recovery In Coronary Heart Disea. JAMA 2003, 289:3106-3116.
22. Bevilacqua M.P., Schleef R.R., Gimbrone M.A., Loskutoff D.J. Regulation of the fibrinolytic system of cultured human vascular endothelium by interleukin 1. J. Clin. Invest. 1986, 78:587-591.
23. Black P.H. The inflammatory response is an integral PART of the stress response: implications for atherosclerosis, insulin resistance, type II diabetes and metabolic syn. Brain Behav. Immun. 2003, 17:350-364.
24. Blumenthal J.A., Jiang W., Babyak M.A., Krantz D.S., Frid D.J., Coleman R.E., et al. Stress management and exercise training in cardiac patients with myocardial ischemia. Effects on prognosis and evaluation of mechanisms. Archives of Internal Medicine 1997, 157:2213-2223.
25. Blumenthal J.A., Jiang W., Waugh R.A., Frid D.J., Morris J.J., Coleman R.E., et al. Mental stress-induced ischemia in the laboratory and ambulatory ischemia during daily life. Association and hemodynamic features. Circulation 1995, 92:2102-2108.
26. Bosch J.A., Berntson G.G., Cacioppo J.T., Dhabhar F.S., Marucha P.T. Acute stress evokes selective mobilization of T cells that differ in chemokine receptor expression: a potential pathway linking immunologic reactivity to card. Brain Behav. Immun. 2003, 17:251-259.
27. Braunwald E. Heart disease 1988, WB Saunders, Philadelphia. 3d ed.
28. Bruce E.C., Musselman D.L. Depression, alterations in platelet function, and ischemic heart disease. Psychosom. Med. 2005, 67(Suppl 1):S34-S36.
29. Bruschke A.V., Kramer J.R., Bal E.T., Haque I.U., Detrano R.C., Goormastic M. The dynamics of progression of coronary atherosclerosis studied in 168 medically treated patients who underwent coronary arteriography three times. Am. Heart J. 1989, 117:296-305.
30. Caligiuri G., Liuzzo G., Biasucci L.M., Maseri A. Immune system activation follows Inflammation in unstable angina: pathogenetic implications. J. Am. Coll. Cardiol. 1998, 32:1295-1304.
31. Carney R.M., Freedland K.E., Rich M.W., Jaffe A.S. Depression as a risk factor for cardiac events in established coronary heart disease: a review of possible mechanisms. Ann. Behav. Med. 1995, 17:142-149.
32. Carney R.M., Freedland K.E., Veith R.C. Depression, the autonomic nervous system, and coronary heart disease. Psychosom. Med. 2005, 67(Suppl 1):S29-S33.
33. Cercek B., Shah P.K., Noc M., Zahger D., Zeymer U., Matetzky S., et al. Effect of short-term treatment with azithromycin on recurrent ischaemic events in patients with acute coronary syndrome in the Azithromycin in Acute Coronary. Lancet 2003, 361:809-813.
34. Cesari M., Penninx B.W., Newman A.B., Kritchevsky S.B., Nicklas B.J., Sutton-Tyrrell K., et al. Inflammatory markers and onset of cardiovascular events: results from the health ABC study. Circulation 2003, 108:2317-2322.
35. Christensen A.J., Edwards D.L., Wiebe J.S., Benotsch E.G., McKelvey L., Andrews M., et al. Effect of verbal selfdisclosure on natural killer cell activity: moderating influence of cynical hostility. Psychosom. Med. 1996, 58:150-155.
36. Danesh J., Collins R., Peto R. Chronic infections and coronary heart disease: is there a link?. Lancet 1997, 350:430-436.
37. Danesh J., Wheeler J.G., Hirschfield G.M., Eda S., Eiriksdottir G., Rumley A., et al. C-reactive protein and other circulating markers of Inflammation in the prediction of coronary heart disease. New England Journal of Medicine 2004, 350:1387-1397.
38. Dantzer R., Kelley K.W. Stress and immunity: an integrated view of relationships between the brain and the immune system. Life Sciences 1989, 44:1995-2008.
39. Davies M.J., Thomas A. Thrombosis and acute coronary-artery lesions in sudden cardiac ischemic death. New England Journal of Medicine 1984, 310:1137-1140.
40. Denollet J., Conraads V.M., Brutsaert D.L., De Clerck L.S., Stevens W.J., Vrints C.J. Cytokines and immune activation in systolic heart failure: the role of type D personality. Brain Behav. Immun. 2003, 17:304-309.
41. Dobson A.J., Alexander H.M., Malcolm J.A., Steele P.L., Miles T.A. Heart attacks and the Newcastle earthquake. Med. J Aust. 1991, 155:757-761.
42. Douglas K.M., Taylor A.J., O'Malley P.G. Relationship between depression and C-reactive protein in a screening population. Psychosom. Med. 2004, 66:679-683.
43. Dugue B., Leppanen E.A., Teppo A.M., Fyhrquist F., Grasbeck R. Effects of psychological stress on plasma interleukins-1 beta and 6, C-reactive protein, tumour necrosis factor alpha, anti-diuretic hormone and serum cortiso. Scandinavian Journal of Clinical and Laboratory Investigation 1993, 53:555-561.
44. Empana J.P., Sykes D.H., Luc G., Juhan-Vague I., Arveiler D., Ferrieres J., et al. Contributions of depressive mood and circulating inflammatory markers to coronary heart disease in healthy European men: the prospective epidemiological study. Circulation 2005, 111:2299-2305.
45. Engebretson T.O., Matthews K.A. Dimensions of hostility in men, women, and boys: relationships to personality and cardiovascular responses to stress. Psychosom. Med. 1992, 54:311-323.
46. Engstrom G., Hedblad B., Stavenow L., Tyden P., Lind P., Janzon L., et al. Fatality of future coronary events is related to Inflammation-sensitive plasma proteins: a population-based prospective cohort study. Circulation 2004, 110:27-31.
47. Entman M.L., Ballantyne C.M. Inflammation in acute coronary syndromes. Circulation 1993, 88:800-803.
48. Fahdi I.E., Gaddam V., Garza L., Romeo F., Mehta J.L. Inflammation, infection, and atherosclerosis. Brain Behav. Immun. 2003, 17:238-244.
49. Falger P.R., Schouten E.G. Exhaustion, psychological stressors in the work environment, and acute myocardial infarction in adult men. Journal of Psychosomatic Research 1992, 36:777-786.
50. Falk E., Shah P.K., Fuster V. Coronary plaque disruption. Circulation 1995, 92:657-671.
51. Fattori R., Piva T. Drug-eluting stents in vascular intervention. Lancet 2003, 361:247-249.
52. Frasure-Smith N., Lesperance F., Prince R.H., Verrier P., Garber R.A., Juneau M., et al. Randomised trial of home-based psychosocial nursing intervention for patients recovering from myocardial infarction. Lancet 1997, 350:473-479.
53. Frasure-Smith N., Prince R. The ischemic heart disease life stress monitoring program: impact on mortality. Psychosom. Med. 1985, 47:431-445.
54. Fricchione G.L., Bilfinger T.V., Hartman A., Liu Y., Stefano G.B. Neuroimmunologic implications in coronary artery disease. Advances in Neuroimmunology 1996, 6:131-142.
55. Friedman M., Rosenman R. Association of specific overt behavior pattern with blood and cardiovascular findings: blood cholesterol level, blood clotting time, incidence of Arcis senili. JAMA 1959, 169:1286-1296.
56. Friedman M., Thoresen C.E., Gill J.J., Ulmer D., Powell L.H., Price V.A., et al. Alteration of type A behavior and its effect on cardiac recurrences in post myocardial infarction patients: summary results of the recurrent coronary preventi. Am. Heart J. 1986, 112:653-665.
57. Fuster V., Badimon L., Badimon J.J., Chesebro J.H. The pathogenesis of coronary artery disease and the acute coronary syndromes (1). New England Journal of Medicine 1992, 326:242-250.
58. Fuster V., Badimon L., Badimon J.J., Chesebro J.H. The pathogenesis of coronary artery disease and the acute coronary syndromes (2). New England Journal of Medicine 1992, 326:310-318.
59. Gidron Y., Armon T., Gilutz H., Huleihel M. Psychological factors correlate meaningfully with percent-monocytes among acute coronary syndrome patients. Brain Behav. Immun. 2003, 17:310-315.
60. Giroud D., Li J.M., Urban P., Meier B., Rutishauer W. Relation of the site of acute myocardial infarction to the most severe coronary arterial stenosis at prior angiography. Am. J. Cardiol. 1992, 69:729-732.
61. Gold P.W., Goodwin F.K., Chrousos G.P. Clinical and biochemical manifestations of depression. relation to the neurobiology of stress (1). New England Journal of Medicine 1988, 319:348-353.
62. Goodkin K., Appels A. Behavioral-neuroendocrineimmunologic interactions in myocardial infarction. Med. Hypotheses 1997, 48:209-214.
63. Grayston J.T., Kronmal R.A., Jackson L.A., Parisi A.F., Muhlestein J.B., Cohen J.D., et al. Azithromycin for the secondary prevention of coronary events. New England Journal of Medicine 2005, 352:1637-1645.
64. Gupta S., Leatham E.W., Carrington D., Mendall M.A., Kaski J.C., Camm A.J. Elevated Chlamydia pneumoniae antibodies, cardiovascular events, and azithromycin in male survivors of myocardial infarction. Circulation 1997, 96:404-407.
65. Gurfinkel E.P., De La Fuente R.L., Mendiz O., Mautner B. Influenza vaccine pilot study in acute coronary syndromes and planned percutaneous coronary interventions: the Flu Vaccination Acute Coronary Syndromes (FLUVA. Circulation 2002, 105:2143-2147.
66. Hansson G.K. Inflammation, atherosclerosis, and coronary artery disease. New England Journal of Medicine 2005, 352:1685-1695.
67. Hansson G.K., Holm J., Holm S., Fotev Z., Hedrich H.J., Fingerle J. T lymphocytes inhibit the vascular response to injury. Proc. Natl. Acad. Sci. USA 1991, 88:10530-10534.
68. Herbert T.B., Cohen S. Depression and immunity: a meta-analytic review. Psychological Bulletin 1993, 113:472-486.
69. Herbert T.B., Cohen S. Stress and immunity in humans: a meta-analytic review. Psychosom. Med. 1993, 55:364-379.
70. Herbert T.B., Cohen S., Marsland A.L., Bachen E.A., Rabin B.S., Muldoon M.F., et al. Cardiovascular reactivity and the course of immune response to an acute psychological stressor. Psychosom. Med. 1994, 56:337-344.
71. Hinderliter A.L., Light K.C., Girdler S.S., Willis P.W., Sherwood A. Blood pressure responses to stress: relation to left ventricular structure and function. Ann. Behav. Med. 1996, 18:61-66.
72. Ikonomidis I., Andreotti F., Economou E., Stefanadis C., Toutouzas P., Nihoyannopoulos P. Increased proin-flammatory cytokines in patients with chronic stable angina and their reduction by aspirin. Circulation 1999, 100:793-798.
73. Jern C., Eriksson E., Tengborn L., Risberg B., Wadenvik H., Jern S. Changes of plasma coagulation and fibrinolysis in response to mental stress. Thrombosis and Haemostasis 1989, 62:761-771.
74. Jeron A., Kaiser T., Straub R.H., Weil J., Riegger G.A., Muders F. Myocardial Il-6 regulation by neurohormones -an in vitro superfusion study. Brain Behav. Immun. 2003, 17:245-250.
75. Kibler J.L., Ma M. Depressive symptoms and cardiovascular reactivity to laboratory behavioral stress. Int. J. Behav. Med. 2004, 11:81-87.
76. Kol A., Libby P. The mechanisms by which infectious agents may contribute to atherosclerosis and its clinical manifestations. Trends Cardiovasc. Med. 1998, 8:191-199.
77. Kop W.J. The predictive value of vital exhaustion in the clinical course after coronary angioplasty 1994, Datawyse, Maastricht.
78. Kop W.J. Acute and chronic psychological risk factors for coronary syndromes: moderating effects of coronary artery disease severity. Journal Psychosom. Res. 1997, 43:167-181.
79. Kop W.J. Chronic and acute psychological risk factors for clinical manifestations of coronary artery disease. Psychosom. Med. 1999, 61:476-487.
80. Kop W.J. The integration of cardiovascular behavioral medicine and psychoneuroimmunology: new developments based on converging research fields. Brain Behav. Immun. 2003, 17:233-237.
81. Kop W.J., Appels A., Howell R.H., Krantz D.S., Bairey Merz C.N., Caravalho J., et al. Relationship between vital exhaustion and stress-induced myocardial ischemia. Ann. Behav. Med. 1997, 19:159.
82. Kop W.J., Appels A., Mendes De Leon C.F., Bar F.W. The relationship between severity of coronary artery disease and vital exhaustion. Journal of Psychosomatic Research 1996, 40:397-405.
83. Kop W.J., Appels A.P., Mendes De Leon C.F., De Swart H., Bar F.W. The effect of successful coronary angioplasty on feelings of exhaustion. Int. J. Cardiol. 1993, 42:269-276.
84. Kop W.J., Appels A.P., Mendes De Leon C.F., De Swart H.B., Bar F.W. Vital exhaustion predicts new cardiac events after successful coronary angioplasty. Psychosom. Med. 1994, 56:281-287.
85. Kop W.J., Cohen N. Psychological risk factors and immune system involvement in cardiovascular disease. Psychoneuroimmunology 2001, 525-544. Academic Press, San Diego. 3rd ed. R. Ader, D. L. Felten, N. Cohen (Eds.).
86. Kop W.J., Gottdiener J.S. The role of immune system parameters in the relationship between depression and coronary artery disease. Psychosom. Med. 2005, 67:537-541.
87. Kop W.J., Gottdiener J.S., Tangen C.M., Fried L.P., McBurnie M.A., Walston J., et al. Inflammation and coagulation factors in persons >65 years of age with symptoms of depression but without evidence of myocardial ischemia. Am. J. Cardiol. 2002, 89:419-424.
88. Kop W.J., Hamulyak K., Pernot K., Appels A. Relationship between blood coagulation and fibrinolysis to vital exhaustion. Psychosom. Med. 1998, 60:352-358.
89. Kop W.J., Krantz D.S., Howell R.H., Ferguson M.A., Papademetriou V., Lu D., et al. Effects of mental stress on coronary epicardial vasomotion and flow velocity in coronary artery disease: relationship with hemodynamic stress responses. J. Am. Coll. Cardiol. 2001, 37:1359-1366.
90. Kop W.J., Zhu J., Doyle M.P., Tracy R.P., Gottdiener J.S., Asch F., et al. Mental stress and exercise effects on immune system and blood coagulation parameters in patients with coronary artery disease following coronary angioplasty. Ann Behav. Med. 2004, S069. (abstract).
91. Kopp M.S., Falger P.R., Appels A., Szedmak S. Depressive symptomatology and vital exhaustion are differentially related to behavioral risk factors for coronary artery disease. Psychosom. Med. 1998, 60:752-758.
92. Krantz D.S., Kop W.J., Santiago H.T., Gottdiener J.S. Mental stress as a trigger of myocardial ischemia and infarction. Cardiology Clinics 1996, 14:271-287.
93. Kraus J.F., Borhani N.O., Franti C.E. Socioeconomic status, ethnicity, and risk of coronary heart disease. Am. J. Epidemiol. 1980, 111:407-414.
94. Kuller L., Cooper M., Perper J. Epidemiology of sudden death. Archives of Internal Medicine 1972, 129:714-719.
95. Kuller L.H., Tracy R.P., Shaten J., Meilahn E.N. Relation of C-reactive protein and coronary heart disease in the MRFIT nested case-control study. Multiple Risk Factor Intervention Trial. Am. J. Epidemiol. 1996, 144:537-547.
96. Ladwig K.H., Marten-Mittag B., Lowel H., Doring A., Koenig W. Influence of depressive mood on the association of CRP and obesity in 3205 middle aged healthy men. Brain Behav. Immun. 2003, 17:268-275.
97. Landmann R.M., Muller F.B., Perini C., Wesp M., Erne P., Buhler F.R. Changes of immunoregulatory cells induced by psychological and physical stress: relationship to plasma catecholamines. Clinical and Experimental Immunology 1984, 58:127-135.
98. Leary T. The genesis of atherosclerosis. Archives of Pathology 1941, 32:507-555.
99. Lee D.J., Meehan R.T., Robinson C., Smith M.L., Mabry T.R. Psychosocial correlates of immune responsiveness and illness episodes in US Air Force Academy cadets undergoing basic cadet training. Journal of Psychosomatic Research 1995, 39:445-457.
100. Lesperance F., Frasure-Smith N. Depression in patients with cardiac disease: a practical review. Journal of Psychosomatic Research 2000, 48:379-391.
101. Lesperance F., Frasure-Smith N., Theroux P., Irwin M. The association between major depression and levels of soluble intercellular adhesion molecule 1, interleukin-6, and C-reactive protein in patients with recen. American Journal of Psychiatry 2004, 161:271-277.
102. Libby P., Egan D., Skarlatos S. Roles of infectious agents in atherosclerosis and restenosis: an assessment of the evidence and need for future research. Circulation 1997, 96:4095-4103.
103. Libby P., Hansson G.K. Involvement of the immune system in human atherogenesis: current knowledge and unanswered questions. Laboratory Investigation 1991, 64:5-15.
104. Libby P., Simon D.I. Inflammation and thrombosis: the clot thickens. Circulation 2001, 103:1718-1720.
105. Libby P., Theroux P. Pathophysiology of coronary artery disease. Circulation 2005, 111:3481-3488.
106. Linden W., Stossel C., Maurice J. Psychosocial interventions for patients with coronary artery disease: a meta-analysis. Archives of Internal Medicine 1996, 156:745-752.
107. Liuzzo G., Biasucci L.M., Gallimore J.R., Grillo R.L., Rebuzzi A.G., Pepys M.B., et al. The prognostic value of Creactive protein and serum amyloid, a protein in severe unstable angina. New England Journal of Medicine 1994, 331:417-424.
108. Liuzzo G., Biasucci L.M., Rebuzzi A.G., Gallimore J.R., Caligiuri G., Lanza G.A., et al. Plasma protein acute-phase response in unstable angina is not induced by ischemic injury. Circulation 1996, 94:2373-2380.
109. Loppnow H., Libby P. Functional significance of human vascular smooth muscle cell-derived interleukin 1 in paracrine and autocrine regulation pathways. Experimental Cell Research 1992, 198:283-290.
110. Maes M. Evidence for an immune response in major depression: a review and hypothesis. Progress in Neuro-Psychopharmacology and Biological Psychiatry 1995, 19:11-38.
111. Manuck S.B., Marsland A.L., Kaplan J.R., Williams J.K. The pathogenicity of behavior and its neuroendocrine mediation: an example from coronary artery disease. Psychosom. Med. 1995, 57:275-283.
112. Markovitz J.H., Matthews K.A. Platelets and coronary heart disease: potential psychophysiologic mechanisms. Psychosom. Med. 1991, 53:643-668.
113. Marmot M.G., Shipley M.J., Rose G. Inequalities in death-specific explanations of a general pattern?. Lancet 1984, 1003-1006.
114. Marsland A.L., Herbert T.B., Muldoon M.F., Bachen E.A., Patterson S., Cohen S., et al. Lymphocyte subset redistribution during acute laboratory stress in young adults: mediating effects of hemoconcentration. Health Psychol. 1997, 16:341-348.
115. McEwen B.S. Protective and damaging effects of stress mediators. New England Journal of Medicine 1998, 338:171-179.
116. McSweeney J.C., Cody M., O'Sullivan P., Elberson K., Moser D.K., Garvin B.J. Women's early warning symptoms of acute myocardial infarction. Circulation 2003, 108:2619-2623.
117. Meesters C.M., Smulders J. Hostility and myocardial infarction in men. J. Psychosom. Res. 1994, 38:727-734.
118. Meisel S.R., Kutz I., Dayan K.I., Pauzner H., Chetboun I., Arbel Y., et al. Effect of Iraqi missile war on incidence of acute myocardial infarction and sudden death in Israeli civilians. Lancet 1991, 338:660-661.
119. Melnick J.L., Adam E., Debakey M.E. Cytomegalovirus and atherosclerosis. Eur. Heart J. 1993, 14(Suppl K):30-38.
120. Mendall M.A., Patel P., Ballam L., Strachan D., Northfield T.C. C reactive protein and its relation to cardiovascular risk factors: a population based cross sectional study. BMJ. 1996, 312:1061-1065.
121. Mendes De Leon C.F., Kop W.J., De Swart H.B., Bar F.W., Appels A.P. Psychosocial characteristics and recurrent events after percutaneous transluminal coronary angioplasty. Am. J. Cardiol. 1996, 77:252-255.
122. Miller G.E., Freedland K.E., Carney R.M., Stetler C.A., Banks W.A. Pathways linking depression, adiposity, and inflammatory markers in healthy young adults. Brain Behav. Immun. 2003, 17:276-285.
123. Miller G.E., Freedland K.E., Duntley S., Carney R.M. Relation of depressive symptoms to C-reactive protein and pathogen burden (cytomegalovirus, herpes simplex virus, Epstein-Barr virus) in patients with earlier. American Journal of Cardiology 2005, 95:317-321.
124. Miller G.E., Stetler C.A., Carney R.M., Freedland K.E. and Banks W.A., Clinical depression and inflammatory risk markers for coronary heart disease. Am. J. Ca.
125. Mills P.J., Dimsdale J.E. The effects of acute psychologic stress on cellular adhesion molecules. Journal of Psychosomatic Research 1996, 41:49-53.
126. Mills P.J., Dimsdale J.E., Nelesen R.A., Dillon E. Psychologic characteristics associated with acute stressorinduced leukocyte subset redistribution. Journal of Psychosomatic Research 1996, 40:417-423.
127. Mills P.J., Farag N.H., Hong S., Kennedy B.P., Berry C.C., Ziegler M.G. Immune cell CD62L and CD11a expression in response to a psychological stressor in human hypertension. Brain Behav. Immun. 2003, 17:260-267.
128. Mittleman M.A., Maclure M., Sherwood J.B., Mulry R.P., Tofler G.H., Jacobs S.C., et al. Triggering of acute myocardial infarction onset by episodes of anger. Determinants of myocardial infarction onset study investigators. Circulation 1995, 92:1720-1725.
129. Muhlestein J.B., Hammond E.H., Carlquist J.F., Radicke E., Thomson M.J., Karagounis L.A., et al. Increased incidence of Chlamydia species within the coronary arteries of patients with symptomatic atherosclerotic versus other forms of cardiovascular diseas. J. Am. Coll. Cardiol. 1996, 27:1555-1561.
130. Muller J.E., Abela G.S., Nesto R.W., Tofler G.H. Triggers, acute risk factors and vulnerable plaques: the lexicon of a new frontier. J. Am. Coll. Cardiol. 1994, 23:809-813.
131. Naghavi M., Libby P., Falk E., Casscells S.W., Litovsky S., Rumberger J., et al. From vulnerable plaque to vulnerable patient: a call for new definitions and risk assessment strategies: PART I. Circulation 2003, 108:1664-1672.
132. Naghavi M., Libby P., Falk E., Casscells S.W., Litovsky S., Rumberger J., et al. From vulnerable plaque to vulnerable patient: a call for new definitions and risk assessment strategies: PART II. Circulation 2003, 108:1772-1778.
133. Owen N., Poulton T., Hay F.C., Mohamed-Ali V., Steptoe A. Socioeconomic status, C-reactive protein, immune factors, and responses to acute mental stress. Brain Behav. Immun. 2003, 17:286-295.
134. Panagiotakos D.B., Pitsavos C., Chrysohoou C., Tsetsekou E., Papageorgiou C., Christodoulou G., et al. Inflammation, coagulation, and depressive symptomatology in cardiovascular disease-free people; the Attica study. Eur. Heart J. 2004, 25:492-499.
135. Pasceri V., Cammarota G., Patti G., Cuoco L., Gasbarrini A., Grillo R.L., et al. Association of virulent Helicobacter pylori strains with ischemic heart disease. Circulation 1998, 97:1675-1679.
136. Pasic J., Levy W.C., Sullivan M.D. Cytokines in depression and heart failure. Psychosom. Med. 2003, 65:181-193.
137. Paterson J., Cottral G.E. Experimental coronary sclerosis III. Lymphomatosis as a cause of coronary sclerosis in chickens. Archives of Pathology 1950, 49:699.
138. Patterson S.M., Gottdiener J.S., Hecht G., Vargot S., Krantz D.S. Effects of acute mental stress on serum lipids: mediating effects of plasma volume. Psychosom. Med. 1993, 55:525-532.
139. Patterson S.M., Krantz D.S., Gottdiener J.S., Hecht G., Vargot S., Goldstein D.S. Prothrombotic effects of environmental stress: changes in platelet function, hematocrit, and total plasma protein. Psychosom. Med. 1995, 57:592-599.
140. Pepine C.J., Hirshfeld J.W., MacDonald R.G., Henderson M.A., Bass T.A., Goldberg S., et al. A controlled trial of corticosteroids to prevent restenosis after coronary angioplasty. MHeart Group. Circulation 1990, 81:1753-1761.
141. Pietraszek M.H., Takada Y., Nishimoto M., Ohara K., Takada A. Fibrinolytic activity in depression and neurosis. Thrombosis Research 1991, 63:661-666.
142. Pike J.L., Irwin M.R. Dissociation of inflammatory markers and natural killer cell activity in major depressive disorder 2005, Immun, Brain Behav.
143. Prasad A., Zhu J., Halcox J.P., Waclawiw M.A., Epstein S.E., Quyyumi A.A. Predisposition to atherosclerosis by infections: role of endothelial dysfunction. Circulation 2002, 106:184-190.
144. Prescott E., Holst C., Gronbaek M., Schnohr P., Jensen G., Barefoot J. Vital exhaustion as a risk factor for ischaemic heart disease and all-cause mortality in a community sample. A prospective study of 4084 men and 5479 women in. International Journal of Epidemiology 2003, 32:990-997.
145. Ragland D.R. Type A behavior and outcome of coronary disease. New England Journal of Medicine 1989, 319:1480-1481.
146. Raikkonen K., Lassila R., Keltikangas-Jarvinen L., Hautanen A. Association of chronic stress with plasminogen activator inhibitor-1 in healthy middle-aged men ss. Arteriosclerosis Thrombosis, and Vascular Biology 1996, 16:363-367.
147. Ridker P.M. Inflammation, infection, and cardiovascular risk: how good is the clinical evidence?. Circulation 1998, 97:1671-1674.
148. Ridker P.M., Cannon C.P., Morrow D., Rifai N., Rose L.M., McCabe C.H., et al. C-reactive protein levels and outcomes after statin therapy. New England Journal of Medicine 2005, 352:20-28.
149. Ridker P.M., Cushman M., Stampfer M.J., Tracy R.P., Hennekens C.H. Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men. New England Journal of Medicine 1997, 336:973-979.
150. Ridker P.M., Glynn R.J., Hennekens C.H. C-reactive protein adds to the predictive value of total and HDL cholesterol in determining risk of first myocardial infarction. Circulation 1998, 97:2007-2011.
151. Ridker P.M., Hennekens C.H., Roitman-Johnson B., Stampfer M.J., Allen J. Plasma concentration of soluble intercellular adhesion molecule 1 and risks of future myocardial infarction in apparently healthy men. Lancet 1998, 351:88-92.
152. Ridker P.M., Rifai N., Pfeffer M., Sacks F., Lepage S., Braunwald E. Elevation of tumor necrosis factor-alpha and increased risk of recurrent coronary events after myocardial infarction. Circulation 2000, 101:2149-2153.
153. Ridker P.M., Rifai N., Stampfer M.J., Hennekens C.H. Plasma concentration of interleukin-6 and the risk of future myocardial infarction among apparently healthy men. Circulation 2000, 101:1767-1772.
154. Roberts R., De Mello V., Sobel B.E. Deleterious effects of methylprednisolone in patients with myocardial infarction. Circulation 1976, 53. I204-I206.
155. Robinette C.D., Fraumeni J.F. Splenectomy and subsequent mortality in veterans of the 1939-45 war. Lancet 1977, 2:127-129.
156. Ross R. The pathogenesis of atherosclerosis: an update. New England Journal of Medicine 1986, 314:488-500.
157. Ross R. Atherosclerosis-an inflammatory disease. New England Journal of Medicine 1999, 340:115-126.
158. Rozanski A., Blumenthal J.A., Kaplan J. Impact of psychological factors on the pathogenesis of cardiovascular disease and implications for therapy. Circulation 1999, 99:2192-2217.
159. Saikku P., Leinonen M., Mattila K., Ekman M.R., Nieminen M.S., Makela P.H., et al. Serological evidence of an association of a novel Chlamydia, Twar, with chronic coronary heart disease and acute myocardial infarction. Lancet 1988, 2:983-986.
160. Sapolsky R., Rivier C., Yamamoto G., Plotsky P., Vale W. Interleukin-1 stimulates the secretion of hypothalamic corticotropin-releasing factor. Science 1987, 238:522-524.
161. Schulte H.M., Bamberger C.M., Elsen H., Herrmann G., Bamberger A.M., Barth J. Systemic interleukin-1 alpha and interleukin-2 secretion in response to acute stress and to corticotropin-releasing hormone in humans. European Journal of Clinical Investigation 1994, 24:773-777.
162. Seeman T.E., Singer B.H., Rowe J.W., Horwitz R.I., McEwen B.S. Price of adaptation-allostatic load and its health consequences. MacArthur studies of successful aging. Archives of Internal Medicine 1997, 157:2259-2268.
163. Segerstrom S.C., Miller G.E. Psychological stress and the human immune system: a meta-analytic study of 30 years of inquiry. Psychological Bulletin 2004, 130:601-630.
164. Selye H. The stress of life 1977, McGraw Hill, New York.
165. Shekelle R.B., Gale M., Norusis M. Type A score (Jenkins Activity Survey) and risk of recurrent coronary heart disease in the Aspirin Myocardial Infarction study. Am. J Cardiol. 1985, 56:221-225.
166. Shekelle R.B., Gale M., Ostfeld A.M., Paul O. Hostility, risk of coronary heart disease, and mortality. Psychosom. Med. 1983, 45:109-114.
167. Siegman A.W., Dembroski T.M., Ringel N. Components of hostility and the severity of coronary artery disease. Psychosom. Med. 1987, 49:127-135.
168. Stein M., Miller A.H., Trestman R.L. Depression, the immune system, and health and illness: findings in search of meaning. Archives of General Psychiatry 1991, 48:171-177.
169. Stern D., Nawroth P., Handley D., Kisiel W. An endothelial cell-dependent pathway of coagulation. Proc. Natl. Acad. Sci USA 1985, 82:2523-2527.
170. Stone G.W., Rutherford B.D., McConahay D.R., Johnson W.L., Giorgi L.V., Ligon R.W., et al. A randomized trial of corticosteroids for the prevention of restenosis in 102 patients undergoing repeat coronary angioplasty. Catheterization and Cardiovascular Diagnosis 1989, 18:227-231.
171. Suarez E.C. Plasma interleukin-6 is associated with psychological coronary risk factors: moderation by use of multivitamin supplements. Brain Behav. Immun. 2003, 17:296-303.
172. Suarez E.C., Williams R.B., Kuhn C.M., Zimmerman E.H., Schanberg S.M. Biobehavioral basis of coronary-prone behavior in middle-age men. PART II: Serum cholesterol, the type A behavior pattern, and hostility as interactive modula. Psychosom. Med. 1991, 53:528-537.
173. Suls J., Bunde J. Anger, anxiety, and depression as risk factors for cardiovascular disease: the problems and implications of overlapping affective dispositions. Psychological Bulletin 2005, 131:260-300.
174. Thompson S.G., Kienast J., Pyke S.D., Haverkate F., Van De Loo J.C. Hemostatic factors and the risk of myocardial infarction or sudden death in patients with angina pectoris. European Concerted Action on Thrombosis and Disabil. New England Journal of Medicine 1995, 332:635-641.
175. Tracey K.J. The inflammatory reflex. Nature 2002, 420:853-859.
176. Tracy R.P., Lemaitre R.N., Psaty B.M., Ives D.G., Evans R.W., Cushman M., et al. Relationship of C-reactive protein to risk of cardiovascular disease in the elderly. Results from the Cardiovascular Health Study and the Rural Health Promoti. Arteriosclerosis, Thrombosis, and Vascular Biology 1997, 17:1121-1127.
177. Trichopoulos D., Katsouyanni K., Zavitsanos X., Tzonou A., Dalla-Vorgia P. Psychological stress and fatal heart attack: The Athens (1981) Earthquake Natural Experiment. Lancet 1983, 1:441-443.
178. Van Dixhoorn J., Duivenvoorden H.J., Staal J.A., Pool J., Verhage F. Cardiac events after myocardial infarction: possible effect of relaxation therapy. Eur. Heart J. 1987, 8:1210-1214.
179. Verrier R.L. Mechanisms of behaviorally induced arrhythmias. Circulation 1987, 76. I48-I56.
180. Von K.R., Mills P.J., Fainman C., Dimsdale J.E. Effects of psychological stress and psychiatric disorders on blood coagulation and fibrinolysis: a biobehavioral pathway to coronary artery disease?. Psychosom. Med. 2001, 63:531-544.
181. Wald N.J., Law M.R., Morris J.K., Bagnall A.M. Helicobacter pylori infection and mortality from ischaemic heart disease: negative result from a large, prospective study. BMJ. 1997, 315:1199-1201.
182. Weisse C.S. Depression and immunocompetence: a review of the literature. Psychological Bulletin 1992, 111:475-489.
183. Welin L., Tibblin G., Svardsudd K., Tibblin B., Ander-Peciva S., Larsson B., et al. Prospective study of social influences on mortality The study of men born in 1913 and 1923. Lancet 1985, 915-918.
184. White P.D. The relationship between infection and fatigue. Journal of Psychosomatic Research 1997, 43:345-350.
185. Williams R.B., Barefoot J.C., Haney T.L., Harrell F.E., Blumenthal J.A., Pryor D.B., et al. Type A behavior and angiographically documented coronary atherosclerosis in a sample of 2,289 patients. Psychosom. Med. 1988, 50:139-152.
186. Williams R.B., Suarez E.C., Kuhn C.M., Zimmerman E.A., Schanberg S.M. Biobehavioral basis of coronary-prone behavior in middle-aged men. PART I: evidence for chronic SNS activation in type As. Psychosom. Med. 1991, 53:517-527.
187. Winkleby M.A., Jatulis D.E., Frank E., Fortmann S.P. Socioeconomic status and health: how education, income, and occupation contribute to risk factors for cardiovascular disease. Am. J. Public Health 1992, 82:816-820.
188. Wojakowski W., Tendera M., Michalowska A., Majka M., Kucia M., Maslankiewicz K., et al. Mobilization of CD34/ CXCR4+, CD34/CD117+, C-Met+ stem cells, and mononuclear cells expressing early cardiac, muscle, and endothelial markers into peripheral. Circulation 2004, 110:3213-3220.
189. Wolfe F., Mitchell D.M., Sibley J.T., Fries J.F., Bloch D.A., Williams C.A., et al. The mortality of rheumatoid arthritis. Arthritis and Rheumatism 1994, 37:481-494.
190. Wright C.E., Strike P.C., Brydon L., Steptoe A. Acute Inflammation and negative mood: mediation by cytokine activation. Brain Behav. Immun. 2005, 19:345-350.
191. Wulsin L.R., Singal B.M. Do depressive symptoms increase the risk for the onset of coronary disease?. A systematic quantitative review. Psychosom. Med. 2003, 65:201-210.
192. Yeung A.C., Vekshtein V.I., Krantz D.S., Vita J.A., Ryan T.J., Ganz P., et al. The effect of atherosclerosis on the vasomotor response of coronary arteries to mental stress. New England Journal of Medicine 1991, 325:1551-1556.
193. Yokoi H., Daida H., Kuwabara Y., Nishikawa H., Takatsu F., Tomihara H., et al. Effectiveness of an antioxidant in preventing restenosis after percutaneous transluminal coronary angioplasty: the Probucol Angioplasty Restenosis trial. J. Am. Coll. Cardiol. 1997, 30:855-862.
194. Yokoya K., Takatsu H., Suzuki T., Hosokawa H., Ojio S., Matsubara T., et al. Process of progression of coronary artery lesions from mild or moderate stenosis to moderate or severe stenosis: a study based on four serial coronary arterio. Circulation 1999, 100:903-909.
195. Zakowski S.G., McAllister C.G., Deal M., Baum A. Stress, reactivity, and immune function in healthy men. Health Psychol. 1992, 11:223-232.
196. Zhu J., Nieto F.J., Horne B.D., Anderson J.L., Muhlestein J.B., Epstein S.E. Prospective study of pathogen burden and risk of myocardial infarction or death. Circulation 2001, 103:45-51.
197. Zorrilla E.P., Luborsky L., McKay J.R., Rosenthal R., Houldin A., Tax A., et al. The relationship of depression and stressors to immunological assays: a meta-analytic review. Brain Behav. Immun. 2001, 15:199-226.